Glyceryl Trinitrate Bristol Laboratories

Glyceryl Trinitrate Bristol Laboratories is a sublingual nitrate vasodilator containing the active ingredient glyceryl trinitrate. Marketed in the European Union as a prescription‑only medication, it is supplied in a rapid‑acting tablet form designed for placement under the tongue. The formulation delivers nitric‑oxide donors to relax vascular smooth muscle, helping to manage angina‑related chest pain and related cardiovascular conditions. It also aims to improve myocardial oxygen balance during episodes of ischemia.

Glyceryl Trinitrate Bristol Laboratories is indicated for several cardiovascular situations where rapid relief of chest pain or reduction of cardiac workload is required.

- Acute angina pectoris attacks, providing quick symptom relief. - Prophylactic use to prevent angina episodes before physical exertion or stress. - Management of heart failure with associated ischemic symptoms. - Treatment of hypertensive emergencies when rapid vasodilation is needed. - Adjunct therapy during cardiac catheterisation to prevent spasm. - Use in combination with other anti‑anginal agents under medical supervision.

Side‑effect profiles for sublingual glyceryl trinitrate include both frequent, mild reactions and rarer, more serious events.

Common: - Headache, often described as throbbing, due to vasodilation. - Flushing or warmth in the face and neck. - Dizziness or light‑headedness, especially when standing quickly. - Low blood pressure (hypotension) causing mild faintness. - Nausea or upset stomach. - Blurred vision.

Serious: - Severe hypotension leading to syncope. - Reflex tachycardia with rapid heart rate. - Methemoglobinemia, a rare disorder affecting oxygen transport. - Allergic skin reaction such as rash or urticaria. - Chest pain worsening despite treatment.

Before prescribing Glyceryl Trinitrate Bristol Laboratories, clinicians consider several precautionary factors to minimise risk and optimise benefit.

- Known hypersensitivity to nitrates or any component of the tablet. - Severe anemia or elevated methemoglobin levels. - Recent use of phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to risk of profound hypotension. - Unstable hemodynamic status, such as shock or severe hypotension. - Concomitant severe aortic stenosis where rapid vasodilation may be hazardous. - Pregnancy and lactation status, as safety data are limited. - Elderly patients who may be more sensitive to blood‑pressure changes.

Glyceryl Trinitrate can interact with other medicines, altering its effectiveness or increasing adverse effects.

Avoid: - Phosphodiesterase‑5 inhibitors (sildenafil, tadalafil, vardenafil) because combined vasodilation may cause dangerous hypotension. - Other nitrate preparations (isosorbide dinitrate, nitroglycerin patches) that can lead to additive nitrate tolerance or severe blood‑pressure drops. - Certain antihypertensive agents (e.g., alpha‑blockers) that may amplify hypotensive effects.

Use with caution: - Beta‑blockers, which may mask tachycardia signs of low blood pressure. - Calcium‑channel blockers, especially dihydropyridines, that can increase vasodilatory response. - Diuretics, as volume depletion may enhance hypotensive risk. - Alcohol, which can potentiate dizziness and low blood pressure.